Igem Therapeutics' Series A Round

Igem Therapeutics raised a round of funding on June 20, 2017. Investors include Epidarex Capital.

Igem Therapeutics is a UK-based immuno-oncology developer. The company is working on a pipeline of antibody candidates that can destroy solid tumors.…

Articles about Igem Therapeutics' Series A Round: